177 Molecular markers for lymph node involvement in advanced cervical carcinomas
Heidi Lyng(Oslo University Hospital), Gitte Kristensen(Norwegian Cancer Society), Ruth Holm(University of Aleppo), Debbie Hege Svendsrud(Norwegian Computing Center), Runar S Brøvig, Olav Kaalhus, H. H. Lien(University of Oslo), Trond Stokke, H. Oksefjell(Norwegian Cancer Society), Kolbein Sundfør(Oslo University Hospital)
Cited by 1
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.
|PubMed|1993|589
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
|PLoS ONE|2011|222
Prognostic significance of TP53 alterations in breast carcinoma
|British Journal of Cancer|1993|168